Selected research
Market Structure
Global CRO Services for BioPharma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global CRO Services for BioPharma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for CRO Services for BioPharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for CRO Services for BioPharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CRO Services for BioPharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for CRO Services for BioPharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of CRO Services for BioPharma include PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, Parexel, ICON plc, Syneos Health and Charles River Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global CRO Services for BioPharma market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of CRO Services for BioPharma and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents CRO Services for BioPharma revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the CRO Services for BioPharma market size, projected growth trends, production technologies, key applications, and end-use industries.
CRO Services for BioPharma Segment by Company
PPD (Thermo Fisher)
Space Peptides
Aurigene Pharmaceutical Services
IQVIA
Labcorp Drug Development
Parexel
ICON plc
Syneos Health
Charles River Laboratories
Medpace
SGS SA
KCR CRO
TFS HealthScience
Caidya
Worldwide Clinical Trials
CTI
Advanced Clinical
WuXi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
JOINN Laboratories
MEDICILON
CRO Services for BioPharma Segment by Type
Preclinical CRO
Clinical Trial CRO
CRO Services for BioPharma Segment by Application
Commercial
Scientific Research
Other
CRO Services for BioPharma Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRO Services for BioPharma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRO Services for BioPharma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRO Services for BioPharma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of CRO Services for BioPharma in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CRO Services for BioPharma industry.
Chapter 3: Detailed analysis of CRO Services for BioPharma companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CRO Services for BioPharmarevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global CRO Services for BioPharma Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032
Table 2. Key Players of Preclinical CRO
Table 3. Key Players of Clinical Trial CRO
Table 4. Global CRO Services for BioPharma Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032
Table 5. Key Players of Commercial
Table 6. Key Players of Scientific Research
Table 7. Key Players of Other
Table 8. Global CRO Services for BioPharma Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 9. Global CRO Services for BioPharma Market Size by Region (2021-2026) & (US$ Million)
Table 10. Global CRO Services for BioPharma Market Share by Region (2021-2026)
Table 11. Global CRO Services for BioPharma Market Size by Region (2027-2032) & (US$ Million)
Table 12. Global CRO Services for BioPharma Market Share by Region (2027-2032)
Table 13. CRO Services for BioPharma Industry Trends
Table 14. CRO Services for BioPharma Industry Drivers
Table 15. CRO Services for BioPharma Industry Opportunities and Challenges
Table 16. CRO Services for BioPharma Industry Restraints
Table 17. Global CRO Services for BioPharma Revenue by Company (US$ Million) & (2021-2026)
Table 18. Global CRO Services for BioPharma Revenue Market Share by Company (2021-2026)
Table 19. Global CRO Services for BioPharma Players Revenue Ranking, 2024 VS 2025 VS 2026
Table 20. Global CRO Services for BioPharma Key Company Head Office and Area Served
Table 21. Global CRO Services for BioPharma Company, Product Type & Application
Table 22. Global CRO Services for BioPharma Company Establishment Date
Table 23. Global Company Market Concentration Ratio (CR5 and HHI)
Table 24. Global CRO Services for BioPharma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 25. Global CRO Services for BioPharma Market Size by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global CRO Services for BioPharma Market Size by Type (2021-2026) & (US$ Million)
Table 27. Global CRO Services for BioPharma Market Size by Type (2027-2032) & (US$ Million)
Table 28. Global CRO Services for BioPharma Revenue Market Share by Type (2021-2026)
Table 29. Global CRO Services for BioPharma Revenue Market Share by Type (2027-2032)
Table 30. Global CRO Services for BioPharma Market Size by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global CRO Services for BioPharma Market Size by Application (2021-2026) & (US$ Million)
Table 32. Global CRO Services for BioPharma Market Size by Application (2027-2032) & (US$ Million)
Table 33. Global CRO Services for BioPharma Revenue Market Share by Application (2021-2026)
Table 34. Global CRO Services for BioPharma Revenue Market Share by Application (2027-2032)
Table 35. PPD (Thermo Fisher) Company Information
Table 36. PPD (Thermo Fisher) Business Overview
Table 37. PPD (Thermo Fisher) CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 38. PPD (Thermo Fisher) CRO Services for BioPharma Product Portfolio
Table 39. PPD (Thermo Fisher) Recent Development
Table 40. Space Peptides Company Information
Table 41. Space Peptides Business Overview
Table 42. Space Peptides CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 43. Space Peptides CRO Services for BioPharma Product Portfolio
Table 44. Space Peptides Recent Development
Table 45. Aurigene Pharmaceutical Services Company Information
Table 46. Aurigene Pharmaceutical Services Business Overview
Table 47. Aurigene Pharmaceutical Services CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 48. Aurigene Pharmaceutical Services CRO Services for BioPharma Product Portfolio
Table 49. Aurigene Pharmaceutical Services Recent Development
Table 50. IQVIA Company Information
Table 51. IQVIA Business Overview
Table 52. IQVIA CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 53. IQVIA CRO Services for BioPharma Product Portfolio
Table 54. IQVIA Recent Development
Table 55. Labcorp Drug Development Company Information
Table 56. Labcorp Drug Development Business Overview
Table 57. Labcorp Drug Development CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 58. Labcorp Drug Development CRO Services for BioPharma Product Portfolio
Table 59. Labcorp Drug Development Recent Development
Table 60. Parexel Company Information
Table 61. Parexel Business Overview
Table 62. Parexel CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 63. Parexel CRO Services for BioPharma Product Portfolio
Table 64. Parexel Recent Development
Table 65. ICON plc Company Information
Table 66. ICON plc Business Overview
Table 67. ICON plc CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 68. ICON plc CRO Services for BioPharma Product Portfolio
Table 69. ICON plc Recent Development
Table 70. Syneos Health Company Information
Table 71. Syneos Health Business Overview
Table 72. Syneos Health CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 73. Syneos Health CRO Services for BioPharma Product Portfolio
Table 74. Syneos Health Recent Development
Table 75. Charles River Laboratories Company Information
Table 76. Charles River Laboratories Business Overview
Table 77. Charles River Laboratories CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 78. Charles River Laboratories CRO Services for BioPharma Product Portfolio
Table 79. Charles River Laboratories Recent Development
Table 80. Medpace Company Information
Table 81. Medpace Business Overview
Table 82. Medpace CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 83. Medpace CRO Services for BioPharma Product Portfolio
Table 84. Medpace Recent Development
Table 85. SGS SA Company Information
Table 86. SGS SA Business Overview
Table 87. SGS SA CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 88. SGS SA CRO Services for BioPharma Product Portfolio
Table 89. SGS SA Recent Development
Table 90. KCR CRO Company Information
Table 91. KCR CRO Business Overview
Table 92. KCR CRO CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 93. KCR CRO CRO Services for BioPharma Product Portfolio
Table 94. KCR CRO Recent Development
Table 95. TFS HealthScience Company Information
Table 96. TFS HealthScience Business Overview
Table 97. TFS HealthScience CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 98. TFS HealthScience CRO Services for BioPharma Product Portfolio
Table 99. TFS HealthScience Recent Development
Table 100. Caidya Company Information
Table 101. Caidya Business Overview
Table 102. Caidya CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 103. Caidya CRO Services for BioPharma Product Portfolio
Table 104. Caidya Recent Development
Table 105. Worldwide Clinical Trials Company Information
Table 106. Worldwide Clinical Trials Business Overview
Table 107. Worldwide Clinical Trials CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 108. Worldwide Clinical Trials CRO Services for BioPharma Product Portfolio
Table 109. Worldwide Clinical Trials Recent Development
Table 110. CTI Company Information
Table 111. CTI Business Overview
Table 112. CTI CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 113. CTI CRO Services for BioPharma Product Portfolio
Table 114. CTI Recent Development
Table 115. Advanced Clinical Company Information
Table 116. Advanced Clinical Business Overview
Table 117. Advanced Clinical CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 118. Advanced Clinical CRO Services for BioPharma Product Portfolio
Table 119. Advanced Clinical Recent Development
Table 120. WuXi AppTec Company Information
Table 121. WuXi AppTec Business Overview
Table 122. WuXi AppTec CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 123. WuXi AppTec CRO Services for BioPharma Product Portfolio
Table 124. WuXi AppTec Recent Development
Table 125. Pharmaron Inc. Company Information
Table 126. Pharmaron Inc. Business Overview
Table 127. Pharmaron Inc. CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 128. Pharmaron Inc. CRO Services for BioPharma Product Portfolio
Table 129. Pharmaron Inc. Recent Development
Table 130. Hangzhou Tigermed Consulting Company Information
Table 131. Hangzhou Tigermed Consulting Business Overview
Table 132. Hangzhou Tigermed Consulting CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 133. Hangzhou Tigermed Consulting CRO Services for BioPharma Product Portfolio
Table 134. Hangzhou Tigermed Consulting Recent Development
Table 135. JOINN Laboratories Company Information
Table 136. JOINN Laboratories Business Overview
Table 137. JOINN Laboratories CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 138. JOINN Laboratories CRO Services for BioPharma Product Portfolio
Table 139. JOINN Laboratories Recent Development
Table 140. MEDICILON Company Information
Table 141. MEDICILON Business Overview
Table 142. MEDICILON CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 143. MEDICILON CRO Services for BioPharma Product Portfolio
Table 144. MEDICILON Recent Development
Table 145. North America CRO Services for BioPharma Market Size by Type (2021-2026) & (US$ Million)
Table 146. North America CRO Services for BioPharma Market Size by Type (2027-2032) & (US$ Million)
Table 147. North America CRO Services for BioPharma Market Size by Application (2021-2026) & (US$ Million)
Table 148. North America CRO Services for BioPharma Market Size by Application (2027-2032) & (US$ Million)
Table 149. North America CRO Services for BioPharma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 150. North America CRO Services for BioPharma Market Size by Country (2021-2026)
Table 151. North America CRO Services for BioPharma Market Size by Country (2027-2032)
Table 152. Europe CRO Services for BioPharma Market Size by Type (2021-2026) & (US$ Million)
Table 153. Europe CRO Services for BioPharma Market Size by Type (2027-2032) & (US$ Million)
Table 154. Europe CRO Services for BioPharma Market Size by Application (2021-2026) & (US$ Million)
Table 155. Europe CRO Services for BioPharma Market Size by Application (2027-2032) & (US$ Million)
Table 156. Europe CRO Services for BioPharma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 157. Europe CRO Services for BioPharma Market Size by Country (2021-2026)
Table 158. Europe CRO Services for BioPharma Market Size by Country (2027-2032)
Table 159. China CRO Services for BioPharma Market Size by Type (2021-2026) & (US$ Million)
Table 160. China CRO Services for BioPharma Market Size by Type (2027-2032) & (US$ Million)
Table 161. China CRO Services for BioPharma Market Size by Application (2021-2026) & (US$ Million)
Table 162. China CRO Services for BioPharma Market Size by Application (2027-2032) & (US$ Million)
Table 163. Asia CRO Services for BioPharma Market Size by Type (2021-2026) & (US$ Million)
Table 164. Asia CRO Services for BioPharma Market Size by Type (2027-2032) & (US$ Million)
Table 165. Asia CRO Services for BioPharma Market Size by Application (2021-2026) & (US$ Million)
Table 166. Asia CRO Services for BioPharma Market Size by Application (2027-2032) & (US$ Million)
Table 167. Asia CRO Services for BioPharma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 168. Asia CRO Services for BioPharma Market Size by Country (2021-2026)
Table 169. Asia CRO Services for BioPharma Market Size by Country (2027-2032)
Table 170. South America, Middle East & Africa CRO Services for BioPharma Market Size by Type (2021-2026) & (US$ Million)
Table 171. South America, Middle East & Africa CRO Services for BioPharma Market Size by Type (2027-2032) & (US$ Million)
Table 172. South America, Middle East & Africa CRO Services for BioPharma Market Size by Application (2021-2026) & (US$ Million)
Table 173. South America, Middle East & Africa CRO Services for BioPharma Market Size by Application (2027-2032) & (US$ Million)
Table 174. South America, Middle East & Africa CRO Services for BioPharma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 175. South America, Middle East & Africa CRO Services for BioPharma Market Size by Country (2021-2026)
Table 176. South America, Middle East & Africa CRO Services for BioPharma Market Size by Country (2027-2032)
Table 177. Research Programs/Design for This Report
Table 178. Authors List of This Report
Table 179. Secondary Sources
Table 180. Primary Sources
List of Figures
Figure 1. CRO Services for BioPharma Product Image
Figure 2. Global CRO Services for BioPharma Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million)
Figure 3. Global CRO Services for BioPharma Market Share by Type: 2025 VS 2032
Figure 4. Preclinical CRO Image
Figure 5. Clinical Trial CRO Image
Figure 6. Global CRO Services for BioPharma Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million)
Figure 7. Global CRO Services for BioPharma Market Share by Application: 2025 VS 2032
Figure 8. Commercial Image
Figure 9. Scientific Research Image
Figure 10. Other Image
Figure 11. Global CRO Services for BioPharma Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 12. Global CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 13. Global CRO Services for BioPharma Market Share by Region: 2025 VS 2032
Figure 14. Years Considered
Figure 15. Global CRO Services for BioPharma Market Share by Players in 2025
Figure 16. Global Top 5 and 10 CRO Services for BioPharma Players Market Share by Revenue in 2025
Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global CRO Services for BioPharma Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global CRO Services for BioPharma Revenue Market Share by Type (2021-2032)
Figure 20. Global CRO Services for BioPharma Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 21. Global CRO Services for BioPharma Revenue Market Share by Application (2021-2032)
Figure 22. North America CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 23. North America CRO Services for BioPharma Market Share by Type (2021-2032)
Figure 24. North America CRO Services for BioPharma Market Share by Application (2021-2032)
Figure 25. North America CRO Services for BioPharma Market Share by Country (2021-2032)
Figure 26. United States CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 27. Canada CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 28. Mexico CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 29. Europe CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 30. Europe CRO Services for BioPharma Market Share by Type (2021-2032)
Figure 31. Europe CRO Services for BioPharma Market Share by Application (2021-2032)
Figure 32. Europe CRO Services for BioPharma Market Share by Country (2021-2032)
Figure 33. Germany CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 34. France CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 35. U.K. CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 36. Italy CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 37. Russia CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 38. Nordic Countries CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 39. China CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 40. China CRO Services for BioPharma Market Share by Type (2021-2032)
Figure 41. China CRO Services for BioPharma Market Share by Application (2021-2032)
Figure 42. Asia CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 43. Asia CRO Services for BioPharma Market Share by Type (2021-2032)
Figure 44. Asia CRO Services for BioPharma Market Share by Application (2021-2032)
Figure 45. Asia CRO Services for BioPharma Market Share by Country (2021-2032)
Figure 46. Japan CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 47. South Korea CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 48. Taiwan CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 49. Southeast Asia CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 50. India CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 51. Australia CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 52. South America, Middle East & Africa CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 53. South America, Middle East & Africa CRO Services for BioPharma Market Share by Type (2021-2032)
Figure 54. South America, Middle East & Africa CRO Services for BioPharma Market Share by Application (2021-2032)
Figure 55. South America, Middle East & Africa CRO Services for BioPharma Market Share by Country (2021-2032)
Figure 56. Brazil CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 57. South Africa CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 58. Saudi Arabia CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 59. Turkey CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 60. Argentina CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 61. UAE CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 62. Egypt CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 63. Chile CRO Services for BioPharma Market Size (2021-2032) & (US$ Million)
Figure 64. Research Process
Figure 65. Key Executives Interviewed
Scope & coverage.
Types
- Preclinical CRO
- Clinical Trial CRO
Applications
- Commercial
- Scientific Research
- Other
Companies covered
- PPD (Thermo Fisher)
- Space Peptides
- Aurigene Pharmaceutical Services
- IQVIA
- Labcorp Drug Development
- Parexel
- ICON plc
- Syneos Health
- Charles River Laboratories
- Medpace
- SGS SA
- KCR CRO
- TFS HealthScience
- Caidya
- Worldwide Clinical Trials
- CTI
- Advanced Clinical
- WuXi AppTec
- Pharmaron Inc.
- Hangzhou Tigermed Consulting
- JOINN Laboratories
- MEDICILON
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global CRO Services for BioPharma Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Preclinical CRO
- 1.2.3 Clinical Trial CRO
- 1.3 Market Analysis by Application
- 1.3.1 Global CRO Services for BioPharma Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Commercial
- 1.3.3 Scientific Research
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global CRO Services for BioPharma Growth Trends by Region
- 1.5.1 Global CRO Services for BioPharma Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 CRO Services for BioPharma Market Size by Region (2021-2026)
- 1.5.3 CRO Services for BioPharma Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global CRO Services for BioPharma Market Dynamics
- 2.1 CRO Services for BioPharma Industry Trends
- 2.2 CRO Services for BioPharma Industry Drivers
- 2.3 CRO Services for BioPharma Industry Opportunities and Challenges
- 2.4 CRO Services for BioPharma Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global CRO Services for BioPharma Revenue by Company (2021-2026)
- 3.2 Global CRO Services for BioPharma Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global CRO Services for BioPharma Key Company Head office and Area Served
- 3.4 Global CRO Services for BioPharma Company, Product Type & Application
- 3.5 Global CRO Services for BioPharma Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global CRO Services for BioPharma Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 CRO Services for BioPharma Players Market Share by Revenue in 2025
- 3.6.3 2025 CRO Services for BioPharma Tier 1, Tier 2, and Tier 3
4 CRO Services for BioPharma Market by Type
- 4.1 Global CRO Services for BioPharma Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global CRO Services for BioPharma Market Size by Type (2021-2032)
- 4.3 Global CRO Services for BioPharma Market Size Share by Type (2021-2032)
5 CRO Services for BioPharma Market by Application
- 5.1 Global CRO Services for BioPharma Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global CRO Services for BioPharma Market Size by Application (2021-2032)
- 5.3 Global CRO Services for BioPharma Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 PPD (Thermo Fisher)
- 6.1.1 PPD (Thermo Fisher) Company Information
- 6.1.2 PPD (Thermo Fisher) Business Overview
- 6.1.3 PPD (Thermo Fisher) CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 PPD (Thermo Fisher) CRO Services for BioPharma Product Portfolio
- 6.1.5 PPD (Thermo Fisher) Recent Developments
- 6.2 Space Peptides
- 6.2.1 Space Peptides Company Information
- 6.2.2 Space Peptides Business Overview
- 6.2.3 Space Peptides CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Space Peptides CRO Services for BioPharma Product Portfolio
- 6.2.5 Space Peptides Recent Developments
- 6.3 Aurigene Pharmaceutical Services
- 6.3.1 Aurigene Pharmaceutical Services Company Information
- 6.3.2 Aurigene Pharmaceutical Services Business Overview
- 6.3.3 Aurigene Pharmaceutical Services CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Aurigene Pharmaceutical Services CRO Services for BioPharma Product Portfolio
- 6.3.5 Aurigene Pharmaceutical Services Recent Developments
- 6.4 IQVIA
- 6.4.1 IQVIA Company Information
- 6.4.2 IQVIA Business Overview
- 6.4.3 IQVIA CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 IQVIA CRO Services for BioPharma Product Portfolio
- 6.4.5 IQVIA Recent Developments
- 6.5 Labcorp Drug Development
- 6.5.1 Labcorp Drug Development Company Information
- 6.5.2 Labcorp Drug Development Business Overview
- 6.5.3 Labcorp Drug Development CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Labcorp Drug Development CRO Services for BioPharma Product Portfolio
- 6.5.5 Labcorp Drug Development Recent Developments
- 6.6 Parexel
- 6.6.1 Parexel Company Information
- 6.6.2 Parexel Business Overview
- 6.6.3 Parexel CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Parexel CRO Services for BioPharma Product Portfolio
- 6.6.5 Parexel Recent Developments
- 6.7 ICON plc
- 6.7.1 ICON plc Company Information
- 6.7.2 ICON plc Business Overview
- 6.7.3 ICON plc CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 ICON plc CRO Services for BioPharma Product Portfolio
- 6.7.5 ICON plc Recent Developments
- 6.8 Syneos Health
- 6.8.1 Syneos Health Company Information
- 6.8.2 Syneos Health Business Overview
- 6.8.3 Syneos Health CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Syneos Health CRO Services for BioPharma Product Portfolio
- 6.8.5 Syneos Health Recent Developments
- 6.9 Charles River Laboratories
- 6.9.1 Charles River Laboratories Company Information
- 6.9.2 Charles River Laboratories Business Overview
- 6.9.3 Charles River Laboratories CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Charles River Laboratories CRO Services for BioPharma Product Portfolio
- 6.9.5 Charles River Laboratories Recent Developments
- 6.10 Medpace
- 6.10.1 Medpace Company Information
- 6.10.2 Medpace Business Overview
- 6.10.3 Medpace CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Medpace CRO Services for BioPharma Product Portfolio
- 6.10.5 Medpace Recent Developments
- 6.11 SGS SA
- 6.11.1 SGS SA Company Information
- 6.11.2 SGS SA Business Overview
- 6.11.3 SGS SA CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 SGS SA CRO Services for BioPharma Product Portfolio
- 6.11.5 SGS SA Recent Developments
- 6.12 KCR CRO
- 6.12.1 KCR CRO Company Information
- 6.12.2 KCR CRO Business Overview
- 6.12.3 KCR CRO CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 KCR CRO CRO Services for BioPharma Product Portfolio
- 6.12.5 KCR CRO Recent Developments
- 6.13 TFS HealthScience
- 6.13.1 TFS HealthScience Company Information
- 6.13.2 TFS HealthScience Business Overview
- 6.13.3 TFS HealthScience CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 TFS HealthScience CRO Services for BioPharma Product Portfolio
- 6.13.5 TFS HealthScience Recent Developments
- 6.14 Caidya
- 6.14.1 Caidya Company Information
- 6.14.2 Caidya Business Overview
- 6.14.3 Caidya CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Caidya CRO Services for BioPharma Product Portfolio
- 6.14.5 Caidya Recent Developments
- 6.15 Worldwide Clinical Trials
- 6.15.1 Worldwide Clinical Trials Company Information
- 6.15.2 Worldwide Clinical Trials Business Overview
- 6.15.3 Worldwide Clinical Trials CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Worldwide Clinical Trials CRO Services for BioPharma Product Portfolio
- 6.15.5 Worldwide Clinical Trials Recent Developments
- 6.16 CTI
- 6.16.1 CTI Company Information
- 6.16.2 CTI Business Overview
- 6.16.3 CTI CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 CTI CRO Services for BioPharma Product Portfolio
- 6.16.5 CTI Recent Developments
- 6.17 Advanced Clinical
- 6.17.1 Advanced Clinical Company Information
- 6.17.2 Advanced Clinical Business Overview
- 6.17.3 Advanced Clinical CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Advanced Clinical CRO Services for BioPharma Product Portfolio
- 6.17.5 Advanced Clinical Recent Developments
- 6.18 WuXi AppTec
- 6.18.1 WuXi AppTec Company Information
- 6.18.2 WuXi AppTec Business Overview
- 6.18.3 WuXi AppTec CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 WuXi AppTec CRO Services for BioPharma Product Portfolio
- 6.18.5 WuXi AppTec Recent Developments
- 6.19 Pharmaron Inc.
- 6.19.1 Pharmaron Inc. Company Information
- 6.19.2 Pharmaron Inc. Business Overview
- 6.19.3 Pharmaron Inc. CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Pharmaron Inc. CRO Services for BioPharma Product Portfolio
- 6.19.5 Pharmaron Inc. Recent Developments
- 6.20 Hangzhou Tigermed Consulting
- 6.20.1 Hangzhou Tigermed Consulting Company Information
- 6.20.2 Hangzhou Tigermed Consulting Business Overview
- 6.20.3 Hangzhou Tigermed Consulting CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Hangzhou Tigermed Consulting CRO Services for BioPharma Product Portfolio
- 6.20.5 Hangzhou Tigermed Consulting Recent Developments
- 6.21 JOINN Laboratories
- 6.21.1 JOINN Laboratories Company Information
- 6.21.2 JOINN Laboratories Business Overview
- 6.21.3 JOINN Laboratories CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 JOINN Laboratories CRO Services for BioPharma Product Portfolio
- 6.21.5 JOINN Laboratories Recent Developments
- 6.22 MEDICILON
- 6.22.1 MEDICILON Company Information
- 6.22.2 MEDICILON Business Overview
- 6.22.3 MEDICILON CRO Services for BioPharma Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.22.4 MEDICILON CRO Services for BioPharma Product Portfolio
- 6.22.5 MEDICILON Recent Developments
7 North America
- 7.1 North America CRO Services for BioPharma Market Size (2021-2032)
- 7.2 North America CRO Services for BioPharma Market Size by Type
- 7.2.1 North America CRO Services for BioPharma Market Size by Type (2021-2026)
- 7.2.2 North America CRO Services for BioPharma Market Size by Type (2027-2032)
- 7.2.3 North America CRO Services for BioPharma Market Share by Type (2021-2032)
- 7.3 North America CRO Services for BioPharma Market Size by Application
- 7.3.1 North America CRO Services for BioPharma Market Size by Application (2021-2026)
- 7.3.2 North America CRO Services for BioPharma Market Size by Application (2027-2032)
- 7.3.3 North America CRO Services for BioPharma Market Share by Application (2021-2032)
- 7.4 North America CRO Services for BioPharma Market Size by Country
- 7.4.1 North America CRO Services for BioPharma Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America CRO Services for BioPharma Market Size by Country (2021-2026)
- 7.4.3 North America CRO Services for BioPharma Market Size by Country (2027-2032)
- 7.4.4 North America CRO Services for BioPharma Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe CRO Services for BioPharma Market Size (2021-2032)
- 8.2 Europe CRO Services for BioPharma Market Size by Type
- 8.2.1 Europe CRO Services for BioPharma Market Size by Type (2021-2026)
- 8.2.2 Europe CRO Services for BioPharma Market Size by Type (2027-2032)
- 8.2.3 Europe CRO Services for BioPharma Market Share by Type (2021-2032)
- 8.3 Europe CRO Services for BioPharma Market Size by Application
- 8.3.1 Europe CRO Services for BioPharma Market Size by Application (2021-2026)
- 8.3.2 Europe CRO Services for BioPharma Market Size by Application (2027-2032)
- 8.3.3 Europe CRO Services for BioPharma Market Share by Application (2021-2032)
- 8.4 Europe CRO Services for BioPharma Market Size by Country
- 8.4.1 Europe CRO Services for BioPharma Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe CRO Services for BioPharma Market Size by Country (2021-2026)
- 8.4.3 Europe CRO Services for BioPharma Market Size by Country (2027-2032)
- 8.4.4 Europe CRO Services for BioPharma Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China CRO Services for BioPharma Market Size (2021-2032)
- 9.2 China CRO Services for BioPharma Market Size by Type
- 9.2.1 China CRO Services for BioPharma Market Size by Type (2021-2026)
- 9.2.2 China CRO Services for BioPharma Market Size by Type (2027-2032)
- 9.2.3 China CRO Services for BioPharma Market Share by Type (2021-2032)
- 9.3 China CRO Services for BioPharma Market Size by Application
- 9.3.1 China CRO Services for BioPharma Market Size by Application (2021-2026)
- 9.3.2 China CRO Services for BioPharma Market Size by Application (2027-2032)
- 9.3.3 China CRO Services for BioPharma Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia CRO Services for BioPharma Market Size (2021-2032)
- 10.2 Asia CRO Services for BioPharma Market Size by Type
- 10.2.1 Asia CRO Services for BioPharma Market Size by Type (2021-2026)
- 10.2.2 Asia CRO Services for BioPharma Market Size by Type (2027-2032)
- 10.2.3 Asia CRO Services for BioPharma Market Share by Type (2021-2032)
- 10.3 Asia CRO Services for BioPharma Market Size by Application
- 10.3.1 Asia CRO Services for BioPharma Market Size by Application (2021-2026)
- 10.3.2 Asia CRO Services for BioPharma Market Size by Application (2027-2032)
- 10.3.3 Asia CRO Services for BioPharma Market Share by Application (2021-2032)
- 10.4 Asia CRO Services for BioPharma Market Size by Country
- 10.4.1 Asia CRO Services for BioPharma Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia CRO Services for BioPharma Market Size by Country (2021-2026)
- 10.4.3 Asia CRO Services for BioPharma Market Size by Country (2027-2032)
- 10.4.4 Asia CRO Services for BioPharma Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa CRO Services for BioPharma Market Size (2021-2032)
- 11.2 South America, Middle East & Africa CRO Services for BioPharma Market Size by Type
- 11.2.1 South America, Middle East & Africa CRO Services for BioPharma Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa CRO Services for BioPharma Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa CRO Services for BioPharma Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa CRO Services for BioPharma Market Size by Application
- 11.3.1 South America, Middle East & Africa CRO Services for BioPharma Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa CRO Services for BioPharma Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa CRO Services for BioPharma Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa CRO Services for BioPharma Market Size by Country
- 11.4.1 South America, Middle East & Africa CRO Services for BioPharma Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa CRO Services for BioPharma Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa CRO Services for BioPharma Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa CRO Services for BioPharma Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst